Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Dora Ho

Immunogenicity, Safety and Consistency of New Trivalent Inactivated Influenza Vaccine

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2008English

Related publications

Immunogenicity and Safety of an Inactivated Trivalent Split Influenza Virus Vaccine in Young Children With Recurrent Wheezing

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2013English

Safety of Trivalent Inactivated Influenza Vaccine in Children Aged 24 to 59 Months in the Vaccine Safety Datalink

Archives of Pediatrics & Adolescent Medicine
2011English

Immunogenicity and Safety of an Egg-Based Inactivated Quadrivalent Influenza Vaccine (GC3110A) Versus Two Inactivated Trivalent Influenza Vaccines With Alternate B Strains: A Phase Ⅲ Randomized Clinical Trial in Adults

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2018English

Immunogenicity and Reactogenicity of High- Versus Standard-Dose Trivalent Inactivated Influenza Vaccine in Healthcare Workers: A Pilot Randomized Controlled Trial

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

538 Severity of Breakthrough Influenza Illness Among Children and Adults Receiving Live Attenuated Influenza Vaccine and Trivalent Inactivated Influenza Vaccine

Pediatric Research
Child HealthPediatricsPerinatology
2010English

Immunogenicity Studies in Human Subjects of Trivalent Tissue Culture Poliomyelitis Vaccine Inactivated by Ultraviolet Irradiation

American Journal of Public Health and the Nations Health
1954English

Discordance Between Antibody and T Cell Responses in Recipients of Trivalent Inactivated Influenza Vaccine

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2008English

Phase I Clinical Evaluation of Seasonal Influenza Hemagglutinin (HA) DNA Vaccine Prime Followed by Trivalent Influenza Inactivated Vaccine (IIV3) Boost

Contemporary Clinical Trials
MedicinePharmacology
2015English

Safety and Immunogenicity of a Baculovirus-Expressed Hemagglutinin Influenza Vaccine

JAMA - Journal of the American Medical Association
Medicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy